These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
331 related articles for article (PubMed ID: 35401196)
1. A Comprehensive Review of BET Protein Biochemistry, Physiology, and Pathological Roles. Ali HA; Li Y; Bilal AHM; Qin T; Yuan Z; Zhao W Front Pharmacol; 2022; 13():818891. PubMed ID: 35401196 [TBL] [Abstract][Full Text] [Related]
5. The Bromodomain and Extra-Terminal Domain (BET) Family: Functional Anatomy of BET Paralogous Proteins. Taniguchi Y Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827996 [TBL] [Abstract][Full Text] [Related]
6. Bromodomain and extraterminal domain-containing protein inhibition attenuates acute inflammation after spinal cord injury. Rudman MD; Choi JS; Lee HE; Tan SK; Ayad NG; Lee JK Exp Neurol; 2018 Nov; 309():181-192. PubMed ID: 30134146 [TBL] [Abstract][Full Text] [Related]
7. BET Bromodomain Inhibitors: Novel Design Strategies and Therapeutic Applications. To KKW; Xing E; Larue RC; Li PK Molecules; 2023 Mar; 28(7):. PubMed ID: 37049806 [TBL] [Abstract][Full Text] [Related]
8. BRD4 bimodal binding at promoters and drug-induced displacement at Pol II pause sites associates with I-BET sensitivity. Khoueiry P; Ward Gahlawat A; Petretich M; Michon AM; Simola D; Lam E; Furlong EE; Benes V; Dawson MA; Prinjha RK; Drewes G; Grandi P Epigenetics Chromatin; 2019 Jul; 12(1):39. PubMed ID: 31266503 [TBL] [Abstract][Full Text] [Related]
9. Small-Molecule Targeting of BET Proteins in Cancer. French CA Adv Cancer Res; 2016; 131():21-58. PubMed ID: 27451123 [TBL] [Abstract][Full Text] [Related]
11. The Functions of BET Proteins in Gene Transcription of Biology and Diseases. Cheung KL; Kim C; Zhou MM Front Mol Biosci; 2021; 8():728777. PubMed ID: 34540900 [TBL] [Abstract][Full Text] [Related]
13. Bromodomain and Extra-Terminal Proteins in Brain Physiology and Pathology: BET-ing on Epigenetic Regulation. Martella N; Pensabene D; Varone M; Colardo M; Petraroia M; Sergio W; La Rosa P; Moreno S; Segatto M Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979729 [TBL] [Abstract][Full Text] [Related]
14. Discovery and characterization of bromodomain 2-specific inhibitors of BRDT. Yu Z; Ku AF; Anglin JL; Sharma R; Ucisik MN; Faver JC; Li F; Nyshadham P; Simmons N; Sharma KL; Nagarajan S; Riehle K; Kaur G; Sankaran B; Storl-Desmond M; Palmer SS; Young DW; Kim C; Matzuk MM Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33637650 [TBL] [Abstract][Full Text] [Related]
15. BET proteins: Biological functions and therapeutic interventions. Guo J; Zheng Q; Peng Y Pharmacol Ther; 2023 Mar; 243():108354. PubMed ID: 36739915 [TBL] [Abstract][Full Text] [Related]
16. Bromodomain and extra-terminal inhibitors emerge as potential therapeutic avenues for gastrointestinal cancers. Sun HY; Du ST; Li YY; Deng GT; Zeng FR World J Gastrointest Oncol; 2022 Jan; 14(1):75-89. PubMed ID: 35116104 [TBL] [Abstract][Full Text] [Related]
17. BET Bromodomain Proteins Brd2, Brd3 and Brd4 Selectively Regulate Metabolic Pathways in the Pancreatic β-Cell. Deeney JT; Belkina AC; Shirihai OS; Corkey BE; Denis GV PLoS One; 2016; 11(3):e0151329. PubMed ID: 27008626 [TBL] [Abstract][Full Text] [Related]